国际肿瘤学杂志 ›› 2013, Vol. 40 ›› Issue (8): 605-607.

• 综述 • 上一篇    下一篇

肿瘤坏死因子相关凋亡诱导配体及其受体与肝癌

徐建, 李敬东   

  1. 637000 南充,川北医学院附属医院普外科,肝胆胰肠研究所
  • 出版日期:2013-08-08 发布日期:2013-08-15
  • 通讯作者: 李敬东,E-mail:lijingdong358@126.com E-mail: lijingdong358@126.com

Tumor necrosis factor-related apoptosis inducing ligand and its receptors in hepatocellular carcinoma

XU  Jian, LI  Jing-Dong   

  1. Department of General Surgery,Institute of Hepatobiliary-Pancreatic-Intestinal Diseases, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China
  • Online:2013-08-08 Published:2013-08-15
  • Contact: Corresponding author:LI Jing-dong, E-mail: lijingdong358@126.com E-mail: lijingdong358@126.com

摘要: 肿瘤坏死因子相关凋亡诱导配体(TRAIL)及受体能在肝癌细胞中特异性地表达,并通过死亡受体特异性地诱导肿瘤细胞凋亡TRAIL联合放疗、化疗能有效地克服肿瘤细胞的TRAIL耐受,促进肿瘤细胞凋亡,同时TRAIL的基因治疗在抗肿瘤临床治疗上已得到广泛的应用

关键词: TNF相关凋亡诱导配体, 受体, TNF相关凋亡诱导配体, 肝肿瘤

Abstract: Tumor necrosis factor-related apoptosis inducing ligands (TRAIL) and its receptors can specifically express in hepatocellular carcinoma cells. TRAIL can specifically induce tumor cells apoptosis through death receptors (DRs); TRAIL combined radiation and chemotherapy can effectively overcome the TRAIL resistance of tumor cells, and promote the apoptosis of tumor cells, meanwhile the gene therapy of TRAIL on anti-tumor clinical treatment has been widely used.

Key words: TNF-related apoptosis-inducing ligand, Receptors, TNF-related apoptosis-inducing ligand, Liver neoplasms